Physician profile
Jonathan Holder
NPI 1578669503
$6,430.21
in general payments reported to CMS, 2019-2025
14 companies · $536 in 2025
The $536 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,157 · 2020: $82.82 · 2021: $683 · 2022: $3,668 · 2023: $190 · 2024: $114 · 2025: $536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $840.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $839.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,162.05 | 2019-2022 | |
| Stryker Corporation | $1,851.40 | 2019-2025 | Mako, Variax, Axsos |
| Gotham Surgical Solutions & Devices, INC. | $912.78 | 2021-2025 | |
| Depuy Synthes Sales INC. | $100.55 | 2024-2025 | Monovisc |
| Zimmer Biomet Holdings, INC. | $67.57 | 2025 | Comprehensive Shoulder System |
| Treace Medical Concepts, INC. | $52.28 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $50.39 | 2019-2022 | |
| Djo, LLC | $48.10 | 2025 | Cmf |
| Bioventus LLC | $46.63 | 2024 | Durolane |
| Pacira Therapeutics, INC. | $45.17 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $38.42 | 2019 | |
| Nalu Medical, INC. | $24.99 | 2025 | Nalu Neurostimulation System |
| Fidia Pharma USA INC. | $17.88 | 2019 | |
| Abbvie INC. | $12.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Holder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.